SEARCH

SEARCH BY CITATION

References

  • 1
    Travis WD, Brambilla E, Muller-Hermelink HK et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press, 2004.
  • 2
    Debelenko LV, Swalwell JI, Kelley MJ et al. MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma. Genes Chromosomes Cancer 2000; 28: 5865.
  • 3
    Righi L, Volante M, Rapa I et al. Neuro-endocrine tumours of the lung. A review of relevant pathological and molecular data. Virchows Arch 2007; 451: S51S59.
  • 4
    Asamura H, Kameya T, Matsuno Y et al. Neuroendocrine neoplasms of the lung: A prognostic spectrum. J Clin Oncol 2006; 24: 7076.
  • 5
    Ruffini E, Rena O, Oliaro A et al. Lung tumors with mixed histologic pattern. Clinico-pathologic characteristics and prognostic significance. Eur J Cardiothorac Surg 2002; 22: 701707.
  • 6
    Nicholson SA, Beasley MB, Brambilla E et al. Small cell lung carcinoma (SCLC): A clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 2002; 26: 11841197.
  • 7
    Folpe AL, Gown AM, Lamps LW et al. Thyroid transcription factor-1: Immunohistochemical evaluation in pulmonary neuroendocrine tumors. Mod Pathol 1999; 12: 58.
  • 8
    Kaufmann O, Dietel M. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary snall cell carcinomas and other neuroendocrine carcinomas of various primary sites. Histopathology 2000; 36: 415420.
  • 9
    Lyda MH, Weiss LM. Immunoreactivity for epithelial and neuroendocine antibodies are useful in the differential diagnosis of lung carcinomas. Hum Pathol 2000; 31: 980987.
  • 10
    Lantuejoul S, Moro D, Michalides RJ et al. Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol 1998; 22: 12671276.
  • 11
    Sturm N, Lantuejoul S, Laverriere MH et al. Thyroid transcription factor 1 and cytokeratin 1, 5, 10, 14 (34βE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol 2001; 32: 918925.
  • 12
    Sturm N, Rossi G, Lantuejoul S et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferation with special interest in carcinoids. Hum Pathol 2002; 33: 175182.
  • 13
    Sturm N, Rossi G, Lantuejoul S et al. 34BetaE12 expression along the whole spectrum of neuroendocrine proliferations of the lung, from neuroendocrine cell hyperplasia to small cell carcinoma. Histopathology 2003; 42: 156166.
  • 14
    Sobin LH, Gospodarowicz MK, Wittekind C. International Union Against Cancer: TNM Classification of Malignant Tumours, 7th edn. New York, NY: Wiley-Blackwell, 2009.
  • 15
    Takei H, Asamura H, Maeshima A et al. Large cell neuroendocrine carcinoma of the lung: A clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 2002; 124: 285292.
  • 16
    Sawabata N, Asamura H, Goya T et al. Japanese Lung Cancer Registry Study: First prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol. 2010; 5: 13691375.